Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
1.135
+0.010 (0.85%)
Feb 12, 2025, 1:57 PM EST - Market open
Opus Genetics Stock Forecast
IRD's stock price has decreased by -56.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Opus Genetics stock has a target of 8.00, which predicts an increase of 604.85% from the current stock price of 1.14.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 12, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Opus Genetics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 |
---|---|---|
Strong Buy | 1 | 1 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +604.85% | Dec 12, 2024 |
Financial Forecast
Revenue This Year
15.27M
from 19.05M
Decreased by -19.82%
Revenue Next Year
19.76M
from 15.27M
Increased by 29.37%
EPS This Year
-0.90
from -0.46
EPS Next Year
-0.86
from -0.90
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 34.9M | 41.4M | 64.3M | |||
Avg | 15.3M | 19.8M | 35.9M | |||
Low | 6.9M | 12.0M | 21.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | 83.1% | 171.3% | 225.5% | |||
Avg | -19.8% | 29.4% | 81.7% | |||
Low | -63.7% | -21.7% | 10.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -0.20 | -0.44 | 0.07 | |||
Avg | -0.90 | -0.86 | -0.28 | |||
Low | -1.20 | -1.01 | -0.74 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.